Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.07 USD
Change Today 0.00 / 0.00%
Volume 11.7K
ILNS On Other Exchanges
As of 11:18 AM 10/5/15 All times are local (Market data is delayed by at least 15 minutes).

intellect neurosciences inc (ILNS) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/11/15 - $5.00
52 Week Low
10/1/15 - $0.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

intellect neurosciences inc (ILNS) Related Bloomberg News

View More Bloomberg News

intellect neurosciences inc (ILNS) Related Businessweek News

No Related Businessweek News Found

intellect neurosciences inc (ILNS) Details

Intellect Neurosciences, Inc., a biopharmaceutical company, discovers and develops therapeutic agents for the treatment and prevention of neurodegenerative conditions. Its product candidate includes OX1 (VP 20629), an orally-administered, brain-penetrating, and naturally-occurring copper-binding small molecule, which is in Phase 1 study to Evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral VP 20629 in adult subjects with friedreich's ataxia. The company’s preclinical products comprise TauC3 for the treatment of Alzheimer’s disease; and CONJUMAB-A, an antibody drug conjugate for the treatment of amyloidosis and other types of proteinopathies. The company has a research collaboration agreement with Medical Research Council Technology, as well as license agreements with the University of South Alabama Medical Science Foundation, New York University, AHP Manufacturing BV, and Northwestern University. Intellect Neurosciences, Inc. was founded in 2005 and is based in Englewood Cliffs, New Jersey.

1 Employees
Last Reported Date: 10/14/14
Founded in 2005

intellect neurosciences inc (ILNS) Top Compensated Officers

Chairman, Chief Executive Officer and Chief F...
Total Annual Compensation: $55.0K
Compensation as of Fiscal Year 2014.

intellect neurosciences inc (ILNS) Key Developments

Intellect Neurosciences, Inc. announced delayed annual 10-K filing

On 09/25/2015, Intellect Neurosciences, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Intellect Neurosciences, Inc. will Change its Ticker to ILNSD from ILNS

Effective February 11, 2015, Intellect Neurosciences, Inc. will change its Pink Sheets LLC stock ticker symbol to ILNSD from ILNS.

Intellect Neurosciences, Inc. Approves to Amend the Certificate of Incorporation

On December 19, 2014, Intellect Neurosciences, Inc. held a special meeting of stockholders, at which the company's stockholders approved and authorized to amend the Certificate of Incorporation to effect a reverse stock split of the company's issued and outstanding shares of common stock, par value $0.001 per share, by a ratio of two hundred and fifty for one (250-for-1) such that each two hundred and fifty (250) shares of Common Stock will be combined into one share of Common Stock at any time prior to December 31, 2014, with fractional shares being rounded-up to the nearest whole number.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILNS:US $0.07 USD 0.00

ILNS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ILNS.
View Industry Companies

Industry Analysis


Industry Average

Valuation ILNS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTELLECT NEUROSCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at